The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Toxicology Drug Screening Market Research Report 2025
Synopsis
The global Toxicology Drug Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Toxicology Drug Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Toxicology Drug Screening.
Report Scope
The Toxicology Drug Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Toxicology Drug Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Toxicology Drug Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Inc.
Merck
Bio-Rad Laboratories Inc.
Danaher
Charles River Laboratories International Inc.
Enzo Life Sciences Inc.
Eurofins Scientific
Selvita
Laboratory Corporation of America Holdings
Promega Corporation
The Jackson Laboratory
Agilent Technologies, Inc
Waters
TECHCOMP GROUP
Wuxi AppTec
Segment by Type
Cardiovascular Disease Drug Screening
Obesity Drug Screening
Diabetes Drug Screening
Others
Segment by Application
Hospitals
Clinics
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Toxicology Drug Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Toxicology Drug Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Toxicology Drug Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Toxicology Drug Screening.
Report Scope
The Toxicology Drug Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Toxicology Drug Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Toxicology Drug Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Inc.
Merck
Bio-Rad Laboratories Inc.
Danaher
Charles River Laboratories International Inc.
Enzo Life Sciences Inc.
Eurofins Scientific
Selvita
Laboratory Corporation of America Holdings
Promega Corporation
The Jackson Laboratory
Agilent Technologies, Inc
Waters
TECHCOMP GROUP
Wuxi AppTec
Segment by Type
Cardiovascular Disease Drug Screening
Obesity Drug Screening
Diabetes Drug Screening
Others
Segment by Application
Hospitals
Clinics
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Toxicology Drug Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Toxicology Drug Screening Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cardiovascular Disease Drug Screening
1.2.3 Obesity Drug Screening
1.2.4 Diabetes Drug Screening
1.2.5 Others
1.3 Market by Application
1.3.1 Global Toxicology Drug Screening Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Toxicology Drug Screening Market Perspective (2019-2030)
2.2 Toxicology Drug Screening Growth Trends by Region
2.2.1 Global Toxicology Drug Screening Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Toxicology Drug Screening Historic Market Size by Region (2019-2024)
2.2.3 Toxicology Drug Screening Forecasted Market Size by Region (2025-2030)
2.3 Toxicology Drug Screening Market Dynamics
2.3.1 Toxicology Drug Screening Industry Trends
2.3.2 Toxicology Drug Screening Market Drivers
2.3.3 Toxicology Drug Screening Market Challenges
2.3.4 Toxicology Drug Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Toxicology Drug Screening Players by Revenue
3.1.1 Global Top Toxicology Drug Screening Players by Revenue (2019-2024)
3.1.2 Global Toxicology Drug Screening Revenue Market Share by Players (2019-2024)
3.2 Global Toxicology Drug Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Toxicology Drug Screening Revenue
3.4 Global Toxicology Drug Screening Market Concentration Ratio
3.4.1 Global Toxicology Drug Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Toxicology Drug Screening Revenue in 2023
3.5 Toxicology Drug Screening Key Players Head office and Area Served
3.6 Key Players Toxicology Drug Screening Product Solution and Service
3.7 Date of Enter into Toxicology Drug Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Toxicology Drug Screening Breakdown Data by Type
4.1 Global Toxicology Drug Screening Historic Market Size by Type (2019-2024)
4.2 Global Toxicology Drug Screening Forecasted Market Size by Type (2025-2030)
5 Toxicology Drug Screening Breakdown Data by Application
5.1 Global Toxicology Drug Screening Historic Market Size by Application (2019-2024)
5.2 Global Toxicology Drug Screening Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Toxicology Drug Screening Market Size (2019-2030)
6.2 North America Toxicology Drug Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Toxicology Drug Screening Market Size by Country (2019-2024)
6.4 North America Toxicology Drug Screening Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Toxicology Drug Screening Market Size (2019-2030)
7.2 Europe Toxicology Drug Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Toxicology Drug Screening Market Size by Country (2019-2024)
7.4 Europe Toxicology Drug Screening Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Toxicology Drug Screening Market Size (2019-2030)
8.2 Asia-Pacific Toxicology Drug Screening Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Toxicology Drug Screening Market Size by Region (2019-2024)
8.4 Asia-Pacific Toxicology Drug Screening Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Toxicology Drug Screening Market Size (2019-2030)
9.2 Latin America Toxicology Drug Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Toxicology Drug Screening Market Size by Country (2019-2024)
9.4 Latin America Toxicology Drug Screening Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Toxicology Drug Screening Market Size (2019-2030)
10.2 Middle East & Africa Toxicology Drug Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Toxicology Drug Screening Market Size by Country (2019-2024)
10.4 Middle East & Africa Toxicology Drug Screening Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Detail
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Toxicology Drug Screening Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Toxicology Drug Screening Business (2019-2024)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Toxicology Drug Screening Introduction
11.2.4 Merck Revenue in Toxicology Drug Screening Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Bio-Rad Laboratories Inc.
11.3.1 Bio-Rad Laboratories Inc. Company Detail
11.3.2 Bio-Rad Laboratories Inc. Business Overview
11.3.3 Bio-Rad Laboratories Inc. Toxicology Drug Screening Introduction
11.3.4 Bio-Rad Laboratories Inc. Revenue in Toxicology Drug Screening Business (2019-2024)
11.3.5 Bio-Rad Laboratories Inc. Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Toxicology Drug Screening Introduction
11.4.4 Danaher Revenue in Toxicology Drug Screening Business (2019-2024)
11.4.5 Danaher Recent Development
11.5 Charles River Laboratories International Inc.
11.5.1 Charles River Laboratories International Inc. Company Detail
11.5.2 Charles River Laboratories International Inc. Business Overview
11.5.3 Charles River Laboratories International Inc. Toxicology Drug Screening Introduction
11.5.4 Charles River Laboratories International Inc. Revenue in Toxicology Drug Screening Business (2019-2024)
11.5.5 Charles River Laboratories International Inc. Recent Development
11.6 Enzo Life Sciences Inc.
11.6.1 Enzo Life Sciences Inc. Company Detail
11.6.2 Enzo Life Sciences Inc. Business Overview
11.6.3 Enzo Life Sciences Inc. Toxicology Drug Screening Introduction
11.6.4 Enzo Life Sciences Inc. Revenue in Toxicology Drug Screening Business (2019-2024)
11.6.5 Enzo Life Sciences Inc. Recent Development
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Company Detail
11.7.2 Eurofins Scientific Business Overview
11.7.3 Eurofins Scientific Toxicology Drug Screening Introduction
11.7.4 Eurofins Scientific Revenue in Toxicology Drug Screening Business (2019-2024)
11.7.5 Eurofins Scientific Recent Development
11.8 Selvita
11.8.1 Selvita Company Detail
11.8.2 Selvita Business Overview
11.8.3 Selvita Toxicology Drug Screening Introduction
11.8.4 Selvita Revenue in Toxicology Drug Screening Business (2019-2024)
11.8.5 Selvita Recent Development
11.9 Laboratory Corporation of America Holdings
11.9.1 Laboratory Corporation of America Holdings Company Detail
11.9.2 Laboratory Corporation of America Holdings Business Overview
11.9.3 Laboratory Corporation of America Holdings Toxicology Drug Screening Introduction
11.9.4 Laboratory Corporation of America Holdings Revenue in Toxicology Drug Screening Business (2019-2024)
11.9.5 Laboratory Corporation of America Holdings Recent Development
11.10 Promega Corporation
11.10.1 Promega Corporation Company Detail
11.10.2 Promega Corporation Business Overview
11.10.3 Promega Corporation Toxicology Drug Screening Introduction
11.10.4 Promega Corporation Revenue in Toxicology Drug Screening Business (2019-2024)
11.10.5 Promega Corporation Recent Development
11.11 The Jackson Laboratory
11.11.1 The Jackson Laboratory Company Detail
11.11.2 The Jackson Laboratory Business Overview
11.11.3 The Jackson Laboratory Toxicology Drug Screening Introduction
11.11.4 The Jackson Laboratory Revenue in Toxicology Drug Screening Business (2019-2024)
11.11.5 The Jackson Laboratory Recent Development
11.12 Agilent Technologies, Inc
11.12.1 Agilent Technologies, Inc Company Detail
11.12.2 Agilent Technologies, Inc Business Overview
11.12.3 Agilent Technologies, Inc Toxicology Drug Screening Introduction
11.12.4 Agilent Technologies, Inc Revenue in Toxicology Drug Screening Business (2019-2024)
11.12.5 Agilent Technologies, Inc Recent Development
11.13 Waters
11.13.1 Waters Company Detail
11.13.2 Waters Business Overview
11.13.3 Waters Toxicology Drug Screening Introduction
11.13.4 Waters Revenue in Toxicology Drug Screening Business (2019-2024)
11.13.5 Waters Recent Development
11.14 TECHCOMP GROUP
11.14.1 TECHCOMP GROUP Company Detail
11.14.2 TECHCOMP GROUP Business Overview
11.14.3 TECHCOMP GROUP Toxicology Drug Screening Introduction
11.14.4 TECHCOMP GROUP Revenue in Toxicology Drug Screening Business (2019-2024)
11.14.5 TECHCOMP GROUP Recent Development
11.15 Wuxi AppTec
11.15.1 Wuxi AppTec Company Detail
11.15.2 Wuxi AppTec Business Overview
11.15.3 Wuxi AppTec Toxicology Drug Screening Introduction
11.15.4 Wuxi AppTec Revenue in Toxicology Drug Screening Business (2019-2024)
11.15.5 Wuxi AppTec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Toxicology Drug Screening Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cardiovascular Disease Drug Screening
Table 3. Key Players of Obesity Drug Screening
Table 4. Key Players of Diabetes Drug Screening
Table 5. Key Players of Others
Table 6. Global Toxicology Drug Screening Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Toxicology Drug Screening Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Toxicology Drug Screening Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Toxicology Drug Screening Market Share by Region (2019-2024)
Table 10. Global Toxicology Drug Screening Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Toxicology Drug Screening Market Share by Region (2025-2030)
Table 12. Toxicology Drug Screening Market Trends
Table 13. Toxicology Drug Screening Market Drivers
Table 14. Toxicology Drug Screening Market Challenges
Table 15. Toxicology Drug Screening Market Restraints
Table 16. Global Toxicology Drug Screening Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Toxicology Drug Screening Market Share by Players (2019-2024)
Table 18. Global Top Toxicology Drug Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxicology Drug Screening as of 2023)
Table 19. Ranking of Global Top Toxicology Drug Screening Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Toxicology Drug Screening Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Toxicology Drug Screening Product Solution and Service
Table 23. Date of Enter into Toxicology Drug Screening Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Toxicology Drug Screening Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Toxicology Drug Screening Revenue Market Share by Type (2019-2024)
Table 27. Global Toxicology Drug Screening Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Toxicology Drug Screening Revenue Market Share by Type (2025-2030)
Table 29. Global Toxicology Drug Screening Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Toxicology Drug Screening Revenue Market Share by Application (2019-2024)
Table 31. Global Toxicology Drug Screening Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Toxicology Drug Screening Revenue Market Share by Application (2025-2030)
Table 33. North America Toxicology Drug Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Toxicology Drug Screening Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Toxicology Drug Screening Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Toxicology Drug Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Toxicology Drug Screening Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Toxicology Drug Screening Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Toxicology Drug Screening Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Toxicology Drug Screening Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Toxicology Drug Screening Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Toxicology Drug Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Toxicology Drug Screening Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Toxicology Drug Screening Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Toxicology Drug Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Toxicology Drug Screening Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Toxicology Drug Screening Market Size by Country (2025-2030) & (US$ Million)
Table 48. Thermo Fisher Scientific Inc. Company Detail
Table 49. Thermo Fisher Scientific Inc. Business Overview
Table 50. Thermo Fisher Scientific Inc. Toxicology Drug Screening Product
Table 51. Thermo Fisher Scientific Inc. Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 52. Thermo Fisher Scientific Inc. Recent Development
Table 53. Merck Company Detail
Table 54. Merck Business Overview
Table 55. Merck Toxicology Drug Screening Product
Table 56. Merck Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 57. Merck Recent Development
Table 58. Bio-Rad Laboratories Inc. Company Detail
Table 59. Bio-Rad Laboratories Inc. Business Overview
Table 60. Bio-Rad Laboratories Inc. Toxicology Drug Screening Product
Table 61. Bio-Rad Laboratories Inc. Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 62. Bio-Rad Laboratories Inc. Recent Development
Table 63. Danaher Company Detail
Table 64. Danaher Business Overview
Table 65. Danaher Toxicology Drug Screening Product
Table 66. Danaher Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 67. Danaher Recent Development
Table 68. Charles River Laboratories International Inc. Company Detail
Table 69. Charles River Laboratories International Inc. Business Overview
Table 70. Charles River Laboratories International Inc. Toxicology Drug Screening Product
Table 71. Charles River Laboratories International Inc. Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 72. Charles River Laboratories International Inc. Recent Development
Table 73. Enzo Life Sciences Inc. Company Detail
Table 74. Enzo Life Sciences Inc. Business Overview
Table 75. Enzo Life Sciences Inc. Toxicology Drug Screening Product
Table 76. Enzo Life Sciences Inc. Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 77. Enzo Life Sciences Inc. Recent Development
Table 78. Eurofins Scientific Company Detail
Table 79. Eurofins Scientific Business Overview
Table 80. Eurofins Scientific Toxicology Drug Screening Product
Table 81. Eurofins Scientific Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 82. Eurofins Scientific Recent Development
Table 83. Selvita Company Detail
Table 84. Selvita Business Overview
Table 85. Selvita Toxicology Drug Screening Product
Table 86. Selvita Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 87. Selvita Recent Development
Table 88. Laboratory Corporation of America Holdings Company Detail
Table 89. Laboratory Corporation of America Holdings Business Overview
Table 90. Laboratory Corporation of America Holdings Toxicology Drug Screening Product
Table 91. Laboratory Corporation of America Holdings Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 92. Laboratory Corporation of America Holdings Recent Development
Table 93. Promega Corporation Company Detail
Table 94. Promega Corporation Business Overview
Table 95. Promega Corporation Toxicology Drug Screening Product
Table 96. Promega Corporation Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 97. Promega Corporation Recent Development
Table 98. The Jackson Laboratory Company Detail
Table 99. The Jackson Laboratory Business Overview
Table 100. The Jackson Laboratory Toxicology Drug Screening Product
Table 101. The Jackson Laboratory Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 102. The Jackson Laboratory Recent Development
Table 103. Agilent Technologies, Inc Company Detail
Table 104. Agilent Technologies, Inc Business Overview
Table 105. Agilent Technologies, Inc Toxicology Drug Screening Product
Table 106. Agilent Technologies, Inc Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 107. Agilent Technologies, Inc Recent Development
Table 108. Waters Company Detail
Table 109. Waters Business Overview
Table 110. Waters Toxicology Drug Screening Product
Table 111. Waters Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 112. Waters Recent Development
Table 113. TECHCOMP GROUP Company Detail
Table 114. TECHCOMP GROUP Business Overview
Table 115. TECHCOMP GROUP Toxicology Drug Screening Product
Table 116. TECHCOMP GROUP Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 117. TECHCOMP GROUP Recent Development
Table 118. Wuxi AppTec Company Detail
Table 119. Wuxi AppTec Business Overview
Table 120. Wuxi AppTec Toxicology Drug Screening Product
Table 121. Wuxi AppTec Revenue in Toxicology Drug Screening Business (2019-2024) & (US$ Million)
Table 122. Wuxi AppTec Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Toxicology Drug Screening Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Toxicology Drug Screening Market Share by Type: 2023 VS 2030
Figure 3. Cardiovascular Disease Drug Screening Features
Figure 4. Obesity Drug Screening Features
Figure 5. Diabetes Drug Screening Features
Figure 6. Others Features
Figure 7. Global Toxicology Drug Screening Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Toxicology Drug Screening Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Laboratory Case Studies
Figure 12. Others Case Studies
Figure 13. Toxicology Drug Screening Report Years Considered
Figure 14. Global Toxicology Drug Screening Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Toxicology Drug Screening Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Toxicology Drug Screening Market Share by Region: 2023 VS 2030
Figure 17. Global Toxicology Drug Screening Market Share by Players in 2023
Figure 18. Global Top Toxicology Drug Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxicology Drug Screening as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Toxicology Drug Screening Revenue in 2023
Figure 20. North America Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Toxicology Drug Screening Market Share by Country (2019-2030)
Figure 22. United States Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Toxicology Drug Screening Market Share by Country (2019-2030)
Figure 26. Germany Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Toxicology Drug Screening Market Share by Region (2019-2030)
Figure 34. China Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Toxicology Drug Screening Market Share by Country (2019-2030)
Figure 42. Mexico Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Toxicology Drug Screening Market Share by Country (2019-2030)
Figure 46. Turkey Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Toxicology Drug Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Thermo Fisher Scientific Inc. Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 49. Merck Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 50. Bio-Rad Laboratories Inc. Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 51. Danaher Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 52. Charles River Laboratories International Inc. Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 53. Enzo Life Sciences Inc. Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 54. Eurofins Scientific Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 55. Selvita Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 56. Laboratory Corporation of America Holdings Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 57. Promega Corporation Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 58. The Jackson Laboratory Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 59. Agilent Technologies, Inc Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 60. Waters Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 61. TECHCOMP GROUP Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 62. Wuxi AppTec Revenue Growth Rate in Toxicology Drug Screening Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
